• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同亚型重症肌无力的发病机制中胸腺的不同作用。

The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes.

机构信息

Institute of Pathology, University Medical Centre Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, D-68167 Mannheim, Germany.

出版信息

Autoimmun Rev. 2013 Jul;12(9):875-84. doi: 10.1016/j.autrev.2013.03.007. Epub 2013 Mar 25.

DOI:10.1016/j.autrev.2013.03.007
PMID:23535159
Abstract

The thymus plays distinct roles in the pathogenesis of the different Myasthenia gravis (MG) subtypes. Inflammatory, neoplastic and age-related alterations of the thymus are of pivotal relevance for the initiation of anti-acetylcholine receptor (AChR) autoimmunity in early onset MG, thymoma-associated MG and, likely, late onset MG, respectively. By contrast, the thymus is presumably not related to MG that is due to autoantibodies to the muscle specific kinase, MuSK. Finally, the role of the thymus is still obscure in MG defined by antibodies against the agrin receptor LRP4 and in MG without all of the above autoantibdies (triple sero-negative MG) since these MG subtypes have been described only recently and thymectomy has not been their standard treatment. This review aims to give an update on intrathymic mechanisms of tolerance breakdown in MG, including abnormal T cell selection and activation, the role of thymic myoid cells, the autoimmune regulator (AIRE) and regulatory T cells.

摘要

胸腺在不同重症肌无力 (MG) 亚型的发病机制中发挥着不同的作用。胸腺的炎症、肿瘤和与年龄相关的改变,对于早期发病的 MG、胸腺瘤相关的 MG 以及可能的迟发性 MG 中抗乙酰胆碱受体 (AChR) 自身免疫的启动至关重要。相比之下,胸腺与由肌肉特异性激酶 (MuSK) 自身抗体引起的 MG 可能没有关系。最后,由于这些 MG 亚型是最近才被描述的,胸腺切除术也不是它们的标准治疗方法,因此在由抗 agrin 受体 LRP4 抗体和无上述所有自身抗体定义的 MG(三重血清阴性 MG)中,胸腺的作用仍然不清楚。本文旨在对 MG 中胸腺内耐受破坏的机制进行综述,包括异常 T 细胞的选择和激活、胸腺肌样细胞、自身免疫调节因子 (AIRE) 和调节性 T 细胞的作用。

相似文献

1
The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes.不同亚型重症肌无力的发病机制中胸腺的不同作用。
Autoimmun Rev. 2013 Jul;12(9):875-84. doi: 10.1016/j.autrev.2013.03.007. Epub 2013 Mar 25.
2
Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.抗肌肉特异性激酶阳性和阴性重症肌无力患者的胸腺变化
Neurology. 2005 Feb 8;64(3):536-8. doi: 10.1212/01.WNL.0000150587.71497.B6.
3
[Seronegative myasthenia gravis].[血清阴性重症肌无力]
Rev Neurol (Paris). 2004 Feb;160(2):159-62. doi: 10.1016/s0035-3787(04)70886-3.
4
Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis.日本胸腺瘤组织学与肌特异性受体酪氨酸激酶抗体阳性重症肌无力伴发自身免疫性疾病的相关性。
Eur J Neurol. 2013 Sep;20(9):1272-6. doi: 10.1111/ene.12169. Epub 2013 May 17.
5
[Myasthenia gravis and autoantibodies: Pathophysiology of the different subtypes].[重症肌无力与自身抗体:不同亚型的病理生理学]
Rev Med Interne. 2014 Jul;35(7):413-20. doi: 10.1016/j.revmed.2013.09.012. Epub 2013 Oct 21.
6
The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.不同抗体的存在及胸腺病理对全身型重症肌无力患者临床结局的预测价值。
Clin Neurol Neurosurg. 2013 Apr;115(4):432-7. doi: 10.1016/j.clineuro.2012.06.013. Epub 2012 Jul 6.
7
Reflections on the "intrathymic pathogenesis" of myasthenia gravis.重症肌无力“胸腺内发病机制”的思考
J Neuroimmunol. 2008 Sep 15;201-202:21-7. doi: 10.1016/j.jneuroim.2008.05.020. Epub 2008 Jul 21.
8
Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.乙酰胆碱受体/肌肉特异性激酶自身抗体阴性重症肌无力的免疫病理特征异质性
J Neuroimmunol. 2007 Sep;189(1-2):163-8. doi: 10.1016/j.jneuroim.2007.07.007. Epub 2007 Aug 15.
9
Myasthenia gravis with anti-acetylcholine receptor antibodies.伴有抗乙酰胆碱受体抗体的重症肌无力
Front Neurol Neurosci. 2009;26:94-108. doi: 10.1159/000212371. Epub 2009 Apr 6.
10
[Autoantibodies detected in acetylcholine receptor antibody-negative myasthenia gravis].[在乙酰胆碱受体抗体阴性重症肌无力中检测到的自身抗体]
Rinsho Byori. 2014 Mar;62(3):255-60.

引用本文的文献

1
Clinicopathological Features and Pathogenesis of Thymoma Complicated with Alopecia Areata: A Multicenter, Matched Case Analysis.胸腺瘤合并斑秃的临床病理特征及发病机制:一项多中心配对病例分析
Cancers (Basel). 2025 Aug 16;17(16):2672. doi: 10.3390/cancers17162672.
2
The efficacy and safety of efgartigimod for refractory myasthenia gravis: a systematic review and meta-analysis.艾加莫德治疗难治性重症肌无力的疗效和安全性:一项系统评价与荟萃分析
Eur J Med Res. 2025 Aug 20;30(1):775. doi: 10.1186/s40001-025-03057-6.
3
Thymic hyperplasia in myasthenia gravis: a narrative review.
重症肌无力中的胸腺增生:一篇综述
Mediastinum. 2025 Jun 25;9:17. doi: 10.21037/med-25-12. eCollection 2025.
4
Circulating inflammatory proteins as pathogenic mediators and potential therapeutic targets in myasthenia gravis.循环炎症蛋白作为重症肌无力的致病介质和潜在治疗靶点
Neurol Sci. 2025 Jun 26. doi: 10.1007/s10072-025-08328-y.
5
Comparison of outcomes and postoperative immunotherapy between patients with non-thymomatous and thymomatous myasthenia gravis following thymectomy.胸腺切除术后非胸腺瘤型与胸腺瘤型重症肌无力患者的预后及术后免疫治疗比较。
Ther Adv Neurol Disord. 2025 Jun 20;18:17562864251343573. doi: 10.1177/17562864251343573. eCollection 2025.
6
Differences Between Females and Males in the Diagnostic Delay and Clinical Course of Thymectomised Myasthenia Gravis.胸腺切除术后重症肌无力患者诊断延迟及临床病程的性别差异
Eur J Neurol. 2025 May;32(5):e70114. doi: 10.1111/ene.70114.
7
Causal Variants in CHRNA1 and CHRNB1 Genes for Anti-acetylcholine Receptor Antibody Positive Myasthenia Gravis: Evidence from Bayesian Fine-Mapping and Genetic Association Study.抗乙酰胆碱受体抗体阳性重症肌无力的CHRNA1和CHRNB1基因中的因果变异:来自贝叶斯精细定位和遗传关联研究的证据。
Mol Neurobiol. 2025 Apr 25. doi: 10.1007/s12035-025-04958-7.
8
Detecting ectopic thymus in thymoma-associated myasthenia gravis through flow cytometry analysis of CD3TCRvβCD4CD8 T cells and its clinical significance.通过CD3TCRvβCD4CD8 T细胞的流式细胞术分析检测胸腺瘤相关重症肌无力中的异位胸腺及其临床意义
Ann Med Surg (Lond). 2025 Feb 11;87(2):515-526. doi: 10.1097/MS9.0000000000002921. eCollection 2025 Feb.
9
Phenotypic patterns and response to immunotherapy in a group of Very Late Onset Myasthenia Gravis: a single center study.一组晚发型重症肌无力的表型模式及免疫治疗反应:一项单中心研究
Neurol Sci. 2025 Apr;46(4):1833-1842. doi: 10.1007/s10072-024-07920-y. Epub 2024 Dec 9.
10
Differentiation and characterization of non-thymomatous ocular myasthenia gravis children with CT.非胸腺瘤性儿童眼肌型重症肌无力的CT鉴别与特征分析
Acta Neurol Belg. 2025 Feb;125(1):149-156. doi: 10.1007/s13760-024-02669-9. Epub 2024 Oct 30.